800-437-4628 INFO@DMSHEALTH.COM
Request a Quote Customer Login
DMS Health
  • Home
  • Solutions
    • Interim Imaging
    • Mobile Imaging
    • Fixed Site Imaging
    • Accessories
  • Modalities
  • Blog
  • About
  • Careers
  • Contact
Select Page
Tauvid: New Alzheimer’s Focused PET Radiopharmaceutical

Tauvid: New Alzheimer’s Focused PET Radiopharmaceutical

by dmsAdmin | Jun 18, 2020 | Alzheimer’s, Radiopharmaceutical

Recently, the FDA provided approval for the use of two new PET radiopharmaceuticals, Cerianna and Tauvid. Cerianna is a molecular imaging agent indicated for use in PET imaging for the detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients...
Understanding the clinical impact of utilizing Axumin (18Fluciclovine)

Understanding the clinical impact of utilizing Axumin (18Fluciclovine)

by dmsAdmin | Jun 13, 2019 | Axumin, Radiopharmaceutical

Axumin (18Fluciclovine) is a radiopharmaceutical that is proving to be a game-changer, particularly in the field of prostate cancer detection. Previously, clinicians in the U.S. had little choice but to use 18FDG to perform the majority of PET/CT imaging. This has...
dms health technologies logo
800-437-4628
INFO@DMSHEALTH.COM
Privacy Agreement
  • Home
  • Interim Imaging
  • Mobile Imaging
  • Fixed Site Imaging
  • Modalities
  • Accessories
  • Blog
  • About
  • Careers
  • Contact
  • Customer Portal
dms accreditation badges

DMS Health Technologies has earned the Joint Commission Goal Seal of Approval and ACR accreditation in multiple modalities — and we are an ISO-9001 certified mobile imaging provider.

All content Copyright © 2023, DMS Health. Knoxville web design and hosting by Slamdot.